Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DR6E | ISIN: CA60255C8850 | Ticker-Symbol: MMQ
Tradegate
26.04.24
19:10 Uhr
7,945 Euro
-0,020
-0,25 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
MIND MEDICINE MINDMED INC Chart 1 Jahr
5-Tage-Chart
MIND MEDICINE MINDMED INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,8708,06513:04
7,8758,05026.04.

Aktuelle News zur MIND MEDICINE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoMindMed to Present at Upcoming May Medical Conferences139Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced...
► Artikel lesen
08.04.Mind Medicine (MindMed) Inc (2): Mind Medicine to be delisted from Cboe Canada62
08.04.MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why34
01.04.MindMed to voluntarily delist from CBOE Canada51
01.04.Mind Medicine Inc. - 8-K, Current Report15
01.04.MindMed Announces Voluntary Delisting from Cboe Canada185NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates...
► Artikel lesen
27.03.Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow13
14.03.MNMD, SMR and VERI are among pre market gainers33
11.03.MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference386Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders...
► Artikel lesen
08.03.MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds15
08.03.MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag15
08.03.Numinus Wellness Inc: Numinus congratulates Mind Medicine on MM120 trial5
08.03.Numinus Wellness Inc.: Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder154VANCOUVER, BC, March 8, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral...
► Artikel lesen
08.03.MindMed gets FDA breakthrough tag for LSD in anxiety11
07.03.MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials19
07.03.Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation18
07.03.Why Is MindMed (MNMD) Stock Up 32% Today?27
07.03.MindMed Receives FDA Breakthrough Therapy Designation For MM120; Stock Up8
07.03.Mind Medicine (MindMed) Inc (2): MindMed's MM120 receives FDA breakthrough designation7
07.03.Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement327Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health...
► Artikel lesen
Seite:  Weiter >>
70 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,7